Provided by Tiger Trade Technology Pte. Ltd.

Catalyst Pharmaceuticals

24.00
-0.1900-0.79%
Post-market: 24.000.00000.00%19:35 EST
Volume:1.43M
Turnover:34.41M
Market Cap:2.95B
PE:14.05
High:24.45
Open:24.07
Low:23.88
Close:24.19
52wk High:26.58
52wk Low:19.05
Shares:122.91M
Float Shares:115.02M
Volume Ratio:0.77
T/O Rate:1.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.71
EPS(LYR):1.38
ROE:27.52%
ROA:17.74%
PB:3.21
PE(LYR):17.35

Loading ...

Stock Track | Catalyst Pharmaceuticals Soars 6.36% After-Hours on Strong Q3 Results, Raised Guidance, and Share Buyback

Stock Track
·
Nov 06

Stock Track | Catalyst Pharmaceuticals Soars 6.36% After Hours on Strong Q3 Results, Raised Guidance

Stock Track
·
Nov 06

BRIEF-Catalyst Pharmaceuticals Q3 Revenue USD 148.4 Million Vs. IBES Estimate USD 136.8 Million

Reuters
·
Nov 06

Santhera Pharmaceuticals Closes $13 Million Royalties Agreement to Support AGAMREE Launch

Reuters
·
Nov 05

Catalyst Pharmaceuticals Recognized Among BioSpace 2026 Best Places to Work

GlobeNewswire
·
Nov 05

Catalyst Pharmaceuticals to Participate in Jefferies Global Healthcare Conference

GlobeNewswire
·
Nov 03

Catalyst Pharmaceuticals (CPRX): Assessing Valuation on Steady Performance and Long-Term Growth Potential

Simply Wall St.
·
Nov 02

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Nov 01

Catalyst Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Oct 30

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Oct 28

Catalyst Pharmaceuticals Inc. Stock Rises Friday, Still Underperforms Market

Dow Jones
·
Oct 25

Catalyst Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Oct 23

Catalyst Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 5, 2025

GlobeNewswire
·
Oct 22

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Oct 21

Catalyst Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Oct 17

Catalyst Pharmaceuticals Inc. Stock Advances 4.7%, Outperforms Peers

Dow Jones
·
Oct 16

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Oct 10

Catalyst Pharmaceuticals announces new real world analyses on Duchenne Muscular Dystrophy and Lambert Eaton Myasthenic Syndrome at upcoming scientific conferences

Reuters
·
Oct 09

Catalyst Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences

GlobeNewswire
·
Oct 09

Catalyst Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Oct 09